Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Daily News

Greater Carotid Plaque Burden in Asthmatic Patients: MESA

Michael O'Riordan

November 24, 2022

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Caitlin E. Cox

August 31, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Conference News EAS 2022

Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively

Michael O'Riordan

May 27, 2022

News Conference News EAS 2022

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

Vasospasm Linked to Higher Atherosclerotic Risk in Patients With ANOCA

Yael L. Maxwell

January 27, 2022

Presentation Controversies and Advances 2021

Pathways for Inflammation in Athero-thrombosis Focus on Inflammasome

Presenter: P. K. Shah

December 03, 2021

Advertisement

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Greater Carotid Plaque Burden in Asthmatic Patients: MESA

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Good News and Bad for High-Intensity Statin Use in ASCVD

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Vasospasm Linked to Higher Atherosclerotic Risk in Patients With ANOCA

Pathways for Inflammation in Athero-thrombosis Focus on Inflammasome

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content